Literature DB >> 18326695

A primate model of nonarteritic anterior ischemic optic neuropathy.

Celia S Chen1, Mary A Johnson, Robert A Flower, Bernard J Slater, Neil R Miller, Steven L Bernstein.   

Abstract

PURPOSE: Nonarteritic anterior ischemic optic neuropathy (NAION) is an optic nerve (ON) stroke and a leading cause of sudden ON-related vision loss. A primate (p)NAION model is crucial to further understanding of the clinical disorder and can provide information regarding the pathophysiology of other central nervous system (CNS) ischemic axonopathies. In the current study, a primate model of NAION was developed, and short-and long-term responses to this condition were characterized.
METHODS: pNAION was induced with a novel photoembolic mechanism. Short-and long-term responses were evaluated by minimally invasive testing (electrophysiology, fundus photography, indocyanine green and fluorescein angiography, and magnetic resonance imaging) and compared with histologic and immunohistochemical findings.
RESULTS: Optic disc edema, similar to that observed in cases of human NAION was seen 1 day after induction, with subsequent resolution associated with the development of optic disc pallor. Magnetic resonance imaging (MRI) performed 3 months after induction revealed changes consistent with ON atrophy. Electrophysiological studies and vascular imaging suggest an ON-limited infarct with subsequent axonal degeneration and selective neuronal loss similar to that seen in human NAION. ON inflammation was evident 2 months after induction at the site of the lesion and at distant sites, suggesting that inflammation-associated axonal remodeling continues for an extended period after ON infarct.
CONCLUSIONS: pNAION resembles human NAION in many respects, with optic disc edema followed by loss of cells in the retinal ganglion cell (RGC) layer and ON remodeling. This model should be useful for evaluating neuroprotective and other treatment strategies for human NAION as well as for other ischemic processes that primarily affect CNS white-matter tracts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18326695      PMCID: PMC2754050          DOI: 10.1167/iovs.07-1651

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  30 in total

1.  Standard for pattern electroretinography. International Society for Clinical Electrophysiology of Vision.

Authors:  M Bach; M Hawlina; G E Holder; M F Marmor; T Meigen; Y Miyake
Journal:  Doc Ophthalmol       Date:  2000-07       Impact factor: 2.379

2.  Standard for clinical electroretinography (2004 update).

Authors:  Michael F Marmor; Graham E Holder; Mathias W Seeliger; Shuichi Yamamoto
Journal:  Doc Ophthalmol       Date:  2004-03       Impact factor: 2.379

Review 3.  Comparison of the unique characteristics of the immune system in different species of mammals.

Authors:  W C Davis; M J Hamilton
Journal:  Vet Immunol Immunopathol       Date:  1998-05-15       Impact factor: 2.046

4.  Incidence of nonarteritic anterior ischemic optic neuropathy.

Authors:  M G Hattenhauer; J A Leavitt; D O Hodge; R Grill; D T Gray
Journal:  Am J Ophthalmol       Date:  1997-01       Impact factor: 5.258

5.  Mechanisms of ischaemic damage to central white matter axons: a quantitative histological analysis using rat optic nerve.

Authors:  G Garthwaite; G Brown; A M Batchelor; D A Goodwin; J Garthwaite
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

6.  Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain.

Authors:  D Ito; K Tanaka; S Suzuki; T Dembo; Y Fukuuchi
Journal:  Stroke       Date:  2001-05       Impact factor: 7.914

Review 7.  Experimental approaches to white matter disease.

Authors:  L Pantoni
Journal:  Dement Geriatr Cogn Disord       Date:  1998-07       Impact factor: 2.959

8.  Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro.

Authors:  Raghuram Selvaraju; Lilia Bernasconi; Christophe Losberger; Pierre Graber; Linda Kadi; Virginia Avellana-Adalid; Nathalie Picard-Riera; Anne Baron Van Evercooren; Rocco Cirillo; Marie Kosco-Vilbois; Georg Feger; Ruben Papoian; Ursula Boschert
Journal:  Mol Cell Neurosci       Date:  2004-04       Impact factor: 4.314

9.  Magnetic resonance imaging of the brain in nonarteritic ischemic optic neuropathy.

Authors:  A C Arnold; R S Hepler; D R Hamilton; R B Lufkin
Journal:  J Neuroophthalmol       Date:  1995-09       Impact factor: 3.042

10.  Fluorescein angiography in nonischemic optic disc edema.

Authors:  A C Arnold; M A Badr; R S Hepler
Journal:  Arch Ophthalmol       Date:  1996-03
View more
  35 in total

Review 1.  The morphological difference between glaucoma and other optic neuropathies.

Authors:  Claude Burgoyne
Journal:  J Neuroophthalmol       Date:  2015-09       Impact factor: 3.042

2.  The non-human primate experimental glaucoma model.

Authors:  Claude F Burgoyne
Journal:  Exp Eye Res       Date:  2015-06-09       Impact factor: 3.467

3.  Evaluation of Choroidal Thickness in Non-arteritic Anterior Ischaemic Optic Neuropathy at the Acute and Chronic Stages.

Authors:  Saban Gonul; Sansal Gedik; Bengu Ekinci Koktekir; Kamil Yavuzer; Suleyman Okudan
Journal:  Neuroophthalmology       Date:  2016-06-30

4.  Subretinal fluid is common in experimental non-arteritic anterior ischemic optic neuropathy.

Authors:  C Yu; J K Ho; Y J Liao
Journal:  Eye (Lond)       Date:  2014-09-26       Impact factor: 3.775

5.  A Single Intravitreal Injection of Ranibizumab Provides No Neuroprotection in a Nonhuman Primate Model of Moderate-to-Severe Nonarteritic Anterior Ischemic Optic Neuropathy.

Authors:  Neil R Miller; Mary A Johnson; Theresa Nolan; Yan Guo; Steven L Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

6.  Optical coherence tomography study of experimental anterior ischemic optic neuropathy and histologic confirmation.

Authors:  Joyce K Ho; Madison P Stanford; Mohammad A Shariati; Roopa Dalal; Yaping Joyce Liao
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-05       Impact factor: 4.799

Review 7.  Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models.

Authors:  Steven L Bernstein; Mary A Johnson; Neil R Miller
Journal:  Prog Retin Eye Res       Date:  2011-03-02       Impact factor: 21.198

Review 8.  Treatment of nonarteritic anterior ischemic optic neuropathy.

Authors:  Edward J Atkins; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  Surv Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 6.048

9.  Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy.

Authors:  N R Miller; A C Arnold
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

Review 10.  Solving the lost in translation problem: improving the effectiveness of translational research.

Authors:  Ceren Ergorul; Leonard A Levin
Journal:  Curr Opin Pharmacol       Date:  2012-09-11       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.